These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33395106)

  • 1. Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance.
    Trinder M; Brunham LR
    Curr Opin Lipidol; 2021 Apr; 32(2):103-111. PubMed ID: 33395106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.
    Dron JS; Wang J; McIntyre AD; Iacocca MA; Robinson JF; Ban MR; Cao H; Hegele RA
    BMC Med Genomics; 2020 Feb; 13(1):23. PubMed ID: 32041611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
    Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S;
    Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic risk scores for the diagnosis and management of dyslipidemia.
    Brunham LR; Trinder M
    Curr Opin Endocrinol Diabetes Obes; 2022 Apr; 29(2):95-100. PubMed ID: 35034034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia.
    Hegele RA; Dron JS
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1970-1981. PubMed ID: 32762461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
    Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE
    Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
    Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
    Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia.
    Gill PK; Dron JS; Berberich AJ; Wang J; McIntyre AD; Cao H; Hegele RA
    J Clin Lipidol; 2021; 15(1):79-87. PubMed ID: 33303402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.
    Wang J; Dron JS; Ban MR; Robinson JF; McIntyre AD; Alazzam M; Zhao PJ; Dilliott AA; Cao H; Huff MW; Rhainds D; Low-Kam C; Dubé MP; Lettre G; Tardif JC; Hegele RA
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2439-2445. PubMed ID: 27765764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
    Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
    Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic risk scores: how much do they add?
    Christoffersen M; Tybjærg-Hansen A
    Curr Opin Lipidol; 2021 Jun; 32(3):157-162. PubMed ID: 33900274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia.
    Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA
    J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monogenic and polygenic causes of low and extremely low LDL-C levels in patients referred to specialty lipid clinics: Genetics of low LDL-C.
    Jakubowski B; Shao Y; McNeal C; Xing C; Ahmad Z
    J Clin Lipidol; 2021; 15(5):658-664. PubMed ID: 34340953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Contribution of GWAS Loci in Familial Dyslipidemias.
    Ripatti P; Rämö JT; Söderlund S; Surakka I; Matikainen N; Pirinen M; Pajukanta P; Sarin AP; Service SK; Laurila PP; Ehnholm C; Salomaa V; Wilson RK; Palotie A; Freimer NB; Taskinen MR; Ripatti S
    PLoS Genet; 2016 May; 12(5):e1006078. PubMed ID: 27227539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial combined hyperlipidemia is a polygenic trait.
    Gill PK; Hegele RA
    Curr Opin Lipidol; 2022 Apr; 33(2):126-132. PubMed ID: 34690300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variants at 30 loci contribute to polygenic dyslipidemia.
    Kathiresan S; Willer CJ; Peloso GM; Demissie S; Musunuru K; Schadt EE; Kaplan L; Bennett D; Li Y; Tanaka T; Voight BF; Bonnycastle LL; Jackson AU; Crawford G; Surti A; Guiducci C; Burtt NP; Parish S; Clarke R; Zelenika D; Kubalanza KA; Morken MA; Scott LJ; Stringham HM; Galan P; Swift AJ; Kuusisto J; Bergman RN; Sundvall J; Laakso M; Ferrucci L; Scheet P; Sanna S; Uda M; Yang Q; Lunetta KL; Dupuis J; de Bakker PI; O'Donnell CJ; Chambers JC; Kooner JS; Hercberg S; Meneton P; Lakatta EG; Scuteri A; Schlessinger D; Tuomilehto J; Collins FS; Groop L; Altshuler D; Collins R; Lathrop GM; Melander O; Salomaa V; Peltonen L; Orho-Melander M; Ordovas JM; Boehnke M; Abecasis GR; Mohlke KL; Cupples LA
    Nat Genet; 2009 Jan; 41(1):56-65. PubMed ID: 19060906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic influences on dyslipidemias.
    Dron JS; Hegele RA
    Curr Opin Lipidol; 2018 Apr; 29(2):133-143. PubMed ID: 29300201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
    Futema M; Bourbon M; Williams M; Humphries SE
    Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
    Chen SN; Ballantyne CM; Gotto AM; Tan Y; Willerson JT; Marian AJ
    J Am Coll Cardiol; 2005 May; 45(10):1611-9. PubMed ID: 15893176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
    D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
    J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.